Moreland Mary K
SEC CIK 1783147 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | EVP | 17.2K | — | $380.2K | 19 | 2021-02-22 | 2026-04-28 |
Most active insiders at ABT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ford Robert B | COB AND CEO, Dir | $2.01M | $46.20M |
| 2 | STARKS DANIEL J | Dir | $2.01M | — |
| 3 | Morrone Louis H. | EVP | — | $774.7K |
| 4 | Shroff Eric | SVP | — | $285.0K |
| 5 | Boudreau Philip P | EVP AND CFO | $201.3K | — |
| 6 | Stratton John G | Dir | $173.6K | — |
| 7 | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | — | $102.3K |
| 8 | Moreland Mary K | EVP | — | $70.9K |
| 9 | MCCOY JOHN A. JR. | VP AND Ctrl | — | $70.6K |
| 10 | Cushman Elizabeth C. | EVP, GC AND Sec | — | $30.4K |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-04-29 17:09 | 2026-04-28 | ABT | Abbott Laboratories | Moreland Mary K | EVP | I - Discretionary | $94.41 | +5,314 | 17.2K | +45% | +$501.7K |
| 2026-03-03 | 2026-02-27 | ABT | Abbott Laboratories | Moreland Mary K | EVP | F - Tax | $116.26 | -4,630 | 104.9K | -4% | -$538.3K | |
| 2026-03-03 | 2026-03-02 | ABT | Abbott Laboratories | Moreland Mary K | EVP | S - Sale | $115.58 | -613 | 104.3K | -0.6% | -$70.9K | |
| D | 2026-02-26 | 2026-02-24 | ABT | Abbott Laboratories | Moreland Mary K | EVP | A - Grant | $0.00 | +14.0K | 109.5K | +15% | $0 |
| 2025-03-04 | 2025-03-03 | ABT | Abbott Laboratories | Moreland Mary K | EVP | S - Sale | $138.17 | -791 | 95.6K | -0.8% | -$109.3K | |
| 2025-03-04 | 2025-02-28 | ABT | Abbott Laboratories | Moreland Mary K | EVP | F - Tax | $135.87 | -5,598 | 96.4K | -5% | -$760.6K | |
| D | 2025-02-27 | 2025-02-25 | ABT | Abbott Laboratories | Moreland Mary K | EVP | A - Grant | $0.00 | +10.7K | 102.0K | +12% | $0 |
| 2024-03-04 | 2024-03-01 | ABT | Abbott Laboratories | Moreland Mary K | EVP | S - Sale | $118.50 | -676 | 91.3K | -0.7% | -$80.1K | |
| 2024-03-04 | 2024-02-29 | ABT | Abbott Laboratories | Moreland Mary K | EVP | F - Tax | $120.05 | -5,862 | 91.9K | -6% | -$703.7K | |
| D | 2024-02-23 | 2024-02-21 | ABT | Abbott Laboratories | Moreland Mary K | EVP | A - Grant | $0.00 | +10.6K | 97.8K | +12% | $0 |
| 2023-03-02 | 2023-02-28 | ABT | Abbott Laboratories | Moreland Mary K | EVP | F - Tax | $99.77 | -5,926 | 87.9K | -6% | -$591.2K | |
| 2023-03-02 | 2023-03-01 | ABT | Abbott Laboratories | Moreland Mary K | EVP | S - Sale | $100.77 | -717 | 87.2K | -0.8% | -$72.3K | |
| D | 2023-02-22 | 2023-02-17 | ABT | Abbott Laboratories | Moreland Mary K | EVP | A - Grant | $0.00 | +12.3K | 93.9K | +15% | $0 |
| 2022-08-03 | 2022-08-01 | ABT | Abbott Laboratories | Moreland Mary K | EVP | F - Tax | $108.84 | -1,245 | 81.6K | -2% | -$135.5K | |
| 2022-03-02 | 2022-02-28 | ABT | Abbott Laboratories | Moreland Mary K | EVP | F - Tax | $122.41 | -4,112 | 82.9K | -5% | -$503.3K | |
| D | 2022-02-23 | 2022-02-18 | ABT | Abbott Laboratories | Moreland Mary K | EVP | A - Grant | $0.00 | +15.8K | 88.2K | +22% | $0 |
| D | 2022-02-23 | 2022-02-22 | ABT | Abbott Laboratories | Moreland Mary K | EVP | F - Tax | $116.79 | -793 | 87.4K | -0.9% | -$92.6K |
| D | 2022-02-23 | 2021-02-22 | ABT | Abbott Laboratories | Moreland Mary K | EVP | S - Sale | $119.31 | -400 | 87.0K | -0.5% | -$47.7K |
| 2021-08-03 | 2021-08-01 | ABT | Abbott Laboratories | Moreland Mary K | EVP | F - Tax | $120.98 | -1,245 | 72.3K | -2% | -$150.6K |
Purchase Sale Sale after option exercise All abbreviations